We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Home Depot, Glaxo, Marriott, DISH and O'Reilly
Read MoreHide Full Article
For Immediate Release
Chicago, IL – February 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Home Depot (HD - Free Report) , Glaxo (GSK - Free Report) , Marriott (MAR - Free Report) , DISH Network and O'Reilly Automotive (ORLY - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Home Depot, Glaxo and Marriott
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot, Glaxo and Marriott. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Home Depot’s shares have gained +26.5% over the last one year, outperforming the Zacks Retail Building Products industry’s +23.5% increase backed by its five-year long trend of beating earnings estimates, which continued in fourth-quarter fiscal 2017. Further, sales topped estimates for the sixth straight quarter.
Results gained from strength in core business as well as relentless focus on affording innovative products, boosting interconnected customer experience and driving productivity. Steady housing market recovery and strong customer demand also remain tailwinds. Further, the company provided an optimistic view for fiscal 2018.
Concurrently, it reiterated financial targets for fiscal 2020 and raised the return on invested capital target to reflect gains from the recent tax reform. However, gross margins continued to be soft due to impacts from lower margin hurricane-related sales. The company anticipates gross margins to decline in fiscal 2018, excluding the 53rd week, due to tight transportation market.
Shares of Glaxo have underperformed the Zacks Large Cap Pharmaceuticals industry over the last year, losing -10.4% versus the industry’s +9.7% increase. Glaxo beat estimates for both earnings and sales in Q4.
The Zacks analyst likes Glaxo’s efforts to develop its pipeline. Performance of new products has been encouraging. Meanwhile, back-to-back approvals of three new products -- Trelegy Ellipta, Shingrix and Juluca -- have strengthened Glaxo’s competitive position.
However, persistent challenges like stiff competition, genericization, pricing pressure and slowing growth in emerging markets have been hurting sales. Pricing pressure and competitive dynamics are hurting sales in Glaxo’s respiratory franchise, particularly the older products.
Meanwhile, its top-selling product, Advair is also expected to face generic competition in the United States this year, which will further hurt sales. The slowdown in sales of the Consumer Healthcare segment in 2017 is also a concern.
Buy-rated Marriott’s shares have outperformed the Zacks Hotels industry over the last one year. (the stock is up +63.2% vs. +42.7% gain for the industry). Marriott is currently benefiting from Starwood acquisition, rising North-American business, sizeable international exposure and an attractive brand-position. The company also saw upward revisions for 2018 earnings over the last 60 days.
Notably, with the acquisition of Starwood, Marriott became the world's largest hotel company. In fact, this buyout is likely to result in a bigger brand with increased scale and a robust development pipeline in the long run.
Yet, lingering political uncertainties in key international markets and currency headwinds might continue to limit revenue growth. Moreover, integration risks linked to Starwood purchase is an added concern. Even so, its investments in technology for hotel bookings are anticipated to improve guest experience.
Other noteworthy reports we are featuring today include DISH Network and O'Reilly Automotive.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Home Depot, Glaxo, Marriott, DISH and O'Reilly
For Immediate Release
Chicago, IL – February 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Home Depot (HD - Free Report) , Glaxo (GSK - Free Report) , Marriott (MAR - Free Report) , DISH Network and O'Reilly Automotive (ORLY - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Home Depot, Glaxo and Marriott
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot, Glaxo and Marriott. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Home Depot’s shares have gained +26.5% over the last one year, outperforming the Zacks Retail Building Products industry’s +23.5% increase backed by its five-year long trend of beating earnings estimates, which continued in fourth-quarter fiscal 2017. Further, sales topped estimates for the sixth straight quarter.
Results gained from strength in core business as well as relentless focus on affording innovative products, boosting interconnected customer experience and driving productivity. Steady housing market recovery and strong customer demand also remain tailwinds. Further, the company provided an optimistic view for fiscal 2018.
Concurrently, it reiterated financial targets for fiscal 2020 and raised the return on invested capital target to reflect gains from the recent tax reform. However, gross margins continued to be soft due to impacts from lower margin hurricane-related sales. The company anticipates gross margins to decline in fiscal 2018, excluding the 53rd week, due to tight transportation market.
Shares of Glaxo have underperformed the Zacks Large Cap Pharmaceuticals industry over the last year, losing -10.4% versus the industry’s +9.7% increase. Glaxo beat estimates for both earnings and sales in Q4.
The Zacks analyst likes Glaxo’s efforts to develop its pipeline. Performance of new products has been encouraging. Meanwhile, back-to-back approvals of three new products -- Trelegy Ellipta, Shingrix and Juluca -- have strengthened Glaxo’s competitive position.
However, persistent challenges like stiff competition, genericization, pricing pressure and slowing growth in emerging markets have been hurting sales. Pricing pressure and competitive dynamics are hurting sales in Glaxo’s respiratory franchise, particularly the older products.
Meanwhile, its top-selling product, Advair is also expected to face generic competition in the United States this year, which will further hurt sales. The slowdown in sales of the Consumer Healthcare segment in 2017 is also a concern.
Buy-rated Marriott’s shares have outperformed the Zacks Hotels industry over the last one year. (the stock is up +63.2% vs. +42.7% gain for the industry). Marriott is currently benefiting from Starwood acquisition, rising North-American business, sizeable international exposure and an attractive brand-position. The company also saw upward revisions for 2018 earnings over the last 60 days.
Notably, with the acquisition of Starwood, Marriott became the world's largest hotel company. In fact, this buyout is likely to result in a bigger brand with increased scale and a robust development pipeline in the long run.
Yet, lingering political uncertainties in key international markets and currency headwinds might continue to limit revenue growth. Moreover, integration risks linked to Starwood purchase is an added concern. Even so, its investments in technology for hotel bookings are anticipated to improve guest experience.
Other noteworthy reports we are featuring today include DISH Network and O'Reilly Automotive.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.